$78.1 M Revs; est. $71.9M
$3.6 M AEBITDA; est. $1.9M
$15.5M GP; est. $13.8M
($ 2.4M) OI; est. ($2.3M)
20% GM; est.19.1%
($ 2.9M) NI; est. ($2.6M)
“The first quarter was an especially strong start to 2024. Canadian Cannabis retail branded sales grew 28% year-over-year, all organically, as we led the top five LPs in market share growth, further narrowing the gap to number one, and achieving a new record in April. Our success in quality, innovation and brand building, together with the support of our provincial boards and retail partners, are driving these results as we delight our consumers.”
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.